![[Logo]FUJIFILM](/en/template/images/gHeader_brandLogo_02.gif){kind=small}
![[Logo]KYOWA KIRIN](/en/template/images/gHeader_brandLogo_01.gif){kind=small}
![[Logo]FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.](/en/template/images/gHeader_coName_01.gif){kind=small}
![[photo]](pack/images/index_mv_01.jpg)
![[photo]](pack/images/index_mv_02.jpg)
![[photo]](pack/images/index_mv_03.jpg)
![[photo]](pack/images/index_mv_04.jpg)
![[photo]](pack/images/index_mv_thumb_01.png)
![[photo]](pack/images/index_mv_thumb_02.png)
![[photo]](pack/images/index_mv_thumb_03.png)
![[photo]](pack/images/index_mv_thumb_04.png)
-
About Biosimilar
![[photo]About Biosimilar](pack/images/index_img_02.jpg)
I will explain biosimilars in an easy-to-understand manner.
-
Our Products
![[photo]Pipeline](pack/images/index_img_01.jpg)
We introduce our products.
-
About us
![[photo]About us](pack/images/index_img_03.jpg)
Basic corporate data for FUJIFILM KYOWA KIRIN BIOLOGICS.
-
Solution
![[photo]Solution](pack/images/index_img_04.jpg)
We will explain our strengths of handling biosimilars.
What's New
- Feb. 15, 2021
- Fujifilm Kyowa Kirin Biologics and Mylan EPD Announce Launch of Biosimilar Adalimumab in Japan
(PDF: 512KB) - Sep. 29, 2020
- Centus Biotherapeutics Receives European Marketing Authorization for Equidacent®, Biosimilar Avastin® (PDF: 76KB)
- Jul. 27, 2020
- Centus Biotherapeutics Announces Positive CHMP Opinion
for FKB238, Biosimilar Bevacizumab (PDF: 492KB)
- Jul. 9, 2020
-
Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp) (PDF: 490KB)
- Jun. 29, 2020
-
Fujifilm Kyowa Kirin Biologics Announces Approval of “Adalimumab (Genetical Recombination) [Adalimumab Biosimilar 1]” in Japan (PDF: 409KB)
